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Abstract. – OBJECTIVE: Early identification 
of Harmful Drinking (HD) is difficult, and under-
estimated. The aim of our retrospective study 
was to investigate the presence of HD in a pop-
ulation of subjects who had their driving license 
suspended due to driving under the influence of 
alcohol. 
MATERIALS AND METHODS: We retrospec-
tively recruited 979 subjects. During the first 
appointment (T0), clinical and laboratory char-
acteristics of patients were evaluated, and the 
AUDIT questionnaire was administered. Two 
groups were then defined: Harmful Drinking 
(HD) and non-HD, and all subjects underwent a 
brief interview for 5-10 minutes before being as-
signed to a group. 
RESULTS: 95.9% of our sample were identi-
fied as non-HD, whereas 4.1% of them were HD; 
twenty-one (2.1%) of the HD underwent a control 
appointment (T1), and 17 (1.7%) of them were di-
agnosed with alcohol use disorder (AUD); there 
was a statistically significant reduction in mean 
daily alcohol intake (p<0.009), and in the mean 
values of the blood markers of HD between T0 
and T1 in HD.
CONCLUSIONS: The present study shows that 
4.1%, and 1.7% of subjects presented a diagno-
sis of HD and AUD, respectively, and their entry 
in a protocol of drinking monitoring proved ben-
eficial in reducing alcohol intake. Thus, the im-
plementation of strict surveillance of subjects 
found driving under the influence of alcohol in-
volving a network of professional figures (from 
police forces to specialists in alcohol addiction 
treatment) may help to detect and to treat sub-
jects with HD and AUD, and to monitor their al-
cohol use over time.
Key Words:
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Introduction
The International Statistical Classification of 
Diseases defines Harmful Drinking (HD) as “a 
pattern of psychoactive substance use that is caus-
ing damage to health. The damage may be physical 
(i.e., as in cases of liver disease due to alcohol mis-
use) or mental (i.e., episodes of depressive disorder 
secondary to heavy consumption of alcohol)”1. 
When HD is associated with symptoms in accor-
dance with the Diagnostic and Statistical Manual 
of Mental Disorder (DSM-V), a diagnosis of Alco-
hol Use Disorder (AUD)2 may be made. 
Despite the availability of simple tools (laborato-
ry tests and questionnaires) for the identification of 
HD in clinical out-patient and inpatient settings1,3,4, 
early identification of HD is still fairly difficult to 
ascertain, and the majority of patients with HD are 
underestimated. Worldwide, the diagnosis of AUD 
is more clearly determined and ranges between 
3% and 15%1,4,5. However, only 30% of patients 
affected by HD or AUD attending a medical setting 
are clearly diagnosed1,4, and only 10% of patients 
with HD and AUD are treated in specific Centers 
for Alcohol Addiction (CAT)1,4. One of the main 
reasons for this underestimation is partially related 
to the fact that subjects with HD and AUD tend to 
be in denial, often not considering their drinking 
habit a problem that needs to be resolved, and rarely 
asking practitioners or specialists for help. In addi-
tion, in order to fill this gap, several studies6-10 have 
investigated the use of alcohol in social contexts 
outside medical settings (i.e., workplaces or drivers 
involved in traffic accidents). However, early identi-
fication of HD in drivers who have had their driving 
license suspended since they have violated the legal 
limit of alcohol use has not been undertaken. 
Thus, the primary outcome of our retrospec-
tive study is to investigate the presence of HD 
in a population of subjects who had their driving 
license suspended while driving under the influ-
ence of alcohol; the secondary outcome was to 
test the efficacy of a strict protocol of drinking 
monitoring to reduce alcohol intake.
Materials and Methods
Protocol of Drinking Monitoring 
After the Suspension of Driving 
Licenses in Italy 
This protocol of drinking monitoring of sub-
jects found driving under the influence of alco-
hol, with only slight inter-regional differences, 
is currently employed in Italy11. All subjects 
found to be positive (>0.5 g of alcohol per liter: 
Italian legal limit of blood alcohol concentration 
for driving)11 for a random breath alcohol test 
performed by the police at road checkpoints are 
subject to an administrative penalty (payment of 
a fine) or a criminal penalty with the suspension 
of their driving license for a period ranging from 
a minimum of 3 months up to 2 years depend-
ing on the level of their electronic breath ana-
lyzer (alcohol test) assessing the blood alcohol 
quantity11. In order to have their driving license 
back, the Italian law obliges them to undergo 
blood exams to identify whether any alterations 
of the common markers of HD [gamma-glu-
tamyltranspeptidase (GGT) (normal value: 5-55 
UI/L); aspartate aminotransferase (AST) (nor-
mal value: 5-50 UI/L), alanine aminotransferase 
(ALT) (normal value: 5-59 UI/L), and mean 
cellular volume (MCV) (normal value: 88-99 
fL), carbohydrate-deficient transferrin (CDT)] 
are present4. With the results of these blood ex-
aminations, after a maximum of 8 weeks from 
the suspension of their driving license, subjects 
attend an appointment at the Local Medical 
Commission of Driving Licenses (LMCDL). If 
the laboratory results are normal and the sub-
jects do not demonstrate any suspicious signs or 
symptoms of HD, the LMCDL authorizes return 
of the driving license (which will be valid only 
at the end of the penalty period), and schedule a 
new control appointment with additional checks 
of the laboratory markers of HD after 3 months, 
6 months, or 1 year. In the case of altered labora-
tory values and/or the presence of specific signs 
and symptoms of HD, a high value of the breath 
alcohol test (>1.5 g/l), in the case of younger 
subjects (<30 years old), and in the case of only 
the alteration of CDT, the LMCDL requires the 
subject to attend a medical appointment at a 
CAT within 4 weeks. Subjects have to make this 
appointment, attend it, and return to the LMC-
DL with a final certification in which confirms: 
a) the use of alcohol is occasional and HD is 
not an issue; b) the use of alcohol is occasional 
and sometimes the subject presents episodes of 
binge drinking (defined as: ≥5 units for men and 
≥4 units for women in about 2 hours)1; c) the use 
of alcohol has the characteristics of HD. The 
LMCDL may then decide to authorize the return 
or not of the driving license for 3 or 6 months; 
in the case of a negative conclusion, the LMC-
DL suggests scheduling a blood test to control 
the markers of HD with a further appointment 
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at the CAT within 4 weeks (Figure 1). Once the 
subjects have attended the appointment, they 
return to the LMCDL, and the commission gives 
the subjects a final conclusive response with 
a program of future monitoring appointments 
(after 3, 6, 12 or 24 months) until they are given 
permission to suspend the protocol.
 
Retrospective Patient Recruitment
We retrospectively recruited 979 subjects, from 
2005 to 2017, sent by the LMCDL for a medical 
appointment to the “G. Fontana” Centre for the 
Diagnosis and Treatment of Alcohol Addiction 
in Bologna, University of Bologna, or to the De-
partment of Internal Medicine in Cento (Ferrara), 
University of Ferrara. All subjects attended the 
appointments as outpatients.
During the first appointment (T0), a physical 
examination was carried out to detect signs or 
symptoms of alcohol intoxication, alcohol with-
drawal or HD; in addition, the amount of alcohol 
intake in the 4 weeks before suspension of the 
driving license, expressed in units of alcohol (1 
unit = 10-12 g of pure alcohol which corresponds 
to 125 ml of wine, or 330 ml of beer, or 40 ml of 
spirits)1 per day or per occasion, was recorded. 
In order to record the amount of alcohol intake, a 
quantity-frequency method to estimate the aver-
age of how many days per week subjects drank, 
and how much they typically consumed alcohol 
on a given drinking day was used12; in addition, 
due to its greater rapidity (about 10-15 minutes to 
administer) this method was the most suitable for 
our setting. Moreover, values of blood laboratory 
markers of HD, and the scores emerging from 
the administration of the Alcohol Use Disorder 
Identification Test (AUDIT)13 were also recorded.
Considering the definition of HD as “a dam-
age to health”1, in order to characterize a patient 
affected by HD, besides signs and symptoms, 
the alterations of blood laboratory markers were 
recorded, while the AUDIT score was consid-
ered with extreme caution since some subjects 
may not declare the real amount of their alcohol 
intake. Namely, alterations of GGT, MCV, AST 
and ALT may reveal initial liver damage and 
malnutrition of subjects due to chronic alcohol 
use4. However, even though CDT is considered 
a common marker of alcohol misuse4, it has a 
very short half-life14,15, and it was not included to 
characterize subjects with HD. In addition, since 
ALT is not specific in identifying alcohol-related 
Figure 1. Example of the Italian monitoring protocol of drinking in a population of subjects whose driving license has been 
suspended as a result of driving under the influence of alcohol. HD: harmful drinking; LMCDL: Local Medical Commission 
of Driving Licenses; CAT: Centers for Alcohol Addiction.
Identification of HD in subjects who have had their driving license suspended due to alcohol use
10723
liver damage4 it was not included in the definition 
of subjects with HD either. Therefore, subjects 
with only alterations of ALT and AST/ALT <1 
(typical of liver damage due to other etiologies 
than alcohol), and elevation of only CDT were 
classified as non-HD, whereas subjects with at 
least two (MCV and GGT) or three (MCV, GGT 
and AST) alterations of the more specific and 
sensitive laboratory markers of alcohol misuse 
were classified as HD. 
Due to the difficulties in contacting almost 
1,000 subjects seen over a very long period of 
time (12 years), informed consent was not ob-
tained. In addition, taking into account that the 
present study is a retrospective analysis without 
sensitive data, approval of the Ethics Committee 
was not formally requested.
The Offered Intervention at the CAT
All subjects attended a brief session consisting 
of counseling for 5-10 minutes aimed at edu-
cating the subjects about problematic drinking, 
increasing motivation to change behavior, and 
reinforcing skills to address problematic drink-
ing16,17. In particular, simple advice was given: a) 
do not drink before driving or during work; b) if 
you decide to drink, do it moderately (not more 
than 2 units of alcohol per day, and not more than 
4 units per occasion for men; not more than 1 unit 
a day, and not more than 3 units per occasion for 
women)18; c) do not drink alcohol on an empty 
stomach, do not use alcohol during pregnan-
cy, and do not use alcohol if you are following 
chronic pharmacological therapy. This advice 
was in accordance with the guidelines of the 
World Health Organization regarding the low risk 
drinking of alcohol intake (<40 g/day of alcohol 
for men, and >20 g/day of alcohol for women)1. If 
symptoms of alcohol withdrawal were identified 
in accordance with the CIWA-Ar score19, oral 
pharmacological treatment with benzodiazepines 
or sodium oxybate to treat symptoms of alcohol 
withdrawal in combination with thiamine to pre-
vent the onset of Wernicke encephalopathy was 
prescribed for 2 weeks4,20. At the end of the first 
appointment (T0), a final certification to be given 
to the LMCDL was issued. The LMCDL could 
then decide to authorize return of the driving 
license or to request to a second follow up ap-
pointment (T1) where subjects have to be tested 
again for the serological markers of HD, and 
where the doctor has to do a further evaluation 
of the clinical condition comparing old and new 
serological markers, re-recording the amount of 
alcohol intake, and re-administration of the AU-
DIT test in association with another brief coun-
seling session. The subject must then return to the 
LMCDL with a second certification. The decision 
of the LMCDL to authorize return of the driving 
license is generally made in consideration of the 
result of the CAT certification, the general clin-
ical characteristic of the patient, age, recurrence 
of the offence, and level of alcohol concentration 
at the time of the breath analyzer control. How-
ever, some of these sensitive data were collected 
only by the LMCDL, and not available for our 
analysis. 
Statistical Analysis
Results are expressed as means ± standard 
deviation. Continuous (age, mean daily number 
of cigarettes, mean daily and occasional alco-
hol intake, mean AUDIT score, mean values of 
laboratory markers of HD) and categorical (gen-
der, employment, smoking) variables between 
males and females, between non-HD and HD 
groups, and within the HD group between T0 
and T1, were analyzed with Student’s t-test and 
chi-square test, respectively. A p-value <0.05 was 
considered to be statistically significant. Data 
analyses were performed using the STATA 15.1 
statistical software program.
Results
Demographic Data and Drinking Habits
The demographic data of our sample with dif-
ferences between males and females are shown in 
Table I. No gender differences were found. Mean 
age was statistically significant higher in the HD 
group with respect to the non-HD group (42.5 ± 
10.8 vs. 41.2 ± 11.8: p<0.0001). A considerable 
number of the whole sample (17%) were <30 years 
old, but none of them were in the HD group. The 
majority of our sample (67.4%) were smokers, and 
no statistically significant difference between sub-
jects with HD and non-HD was shown (p = 0.307); 
however, a statistically significant higher mean 
number of cigarettes smoked in subjects with HD 
vs. those with non-HD (24.0 ± 11.6 vs. 19.6 ± 10.7: 
p<0.039) was found. 
A total of 95.9% of our sample were subjects 
with daily or occasional alcohol intake with the 
characteristic of non-HD, whereas 4.1% of them (n 
= 40; 38 males, and 2 females) were subjects with 
HD. In addition, a statistically significant higher 
mean daily alcohol consumption was recorded in 
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subjects with HD vs. non-HD (4.0 ± 2.5 vs. 2.9 ± 
1.6: p<0.002). Two percent of the whole sample 
were binge drinkers, mostly with non-HD. A sta-
tistically significant higher number of patients with 
an AUDIT score ≥8 points was found in subjects 
with HD vs. non-HD (p<0.0001); however, 50% 
of subjects with HD had a negative AUDIT score. 
Mean values of the laboratory markers of HD were 
statistically significantly higher in subjects with 
HD vs. non-HD (Table II).
At the end of the T0 appointment, 939 sub-
jects (non-HD) returned to the LMCDL with a 
substantially positive certification which would 
guarantee them being allowed to drive for a 
period ranging from 6 to 12 months. Only those 
who presented CDT alterations were required to 
undergo a further control of CDT (not before 2-3 
weeks) and if this proved normal then the LMC-
DL authorized return of their driving license with 
a monitoring protocol to undergo further blood 
markers and an appointment at the LMCDL after 
3 months. Considering the very long period of 
recruitment (12 years), three different methods of 
analysis of the CDT were used, with three differ-
ent cut-offs (Radio Immuno Assay-RIA: cut-off 
= 2.5%; Capillary Electrophoresis-CE: cut-off = 
1.6%; High Performance Liquid Chromatogra-
phy-HPLC: cut-off = 1.8%)21-23, thus it was not 
possible to clearly ascertain the average value of 
CDT across subjects.
The remaining 40 subjects were diagnosed 
with HD. It is worth noting that 3 of them pre-
sented symptoms of moderate alcohol withdrawal 
which needed pharmacological treatment  due to 
a CIWA-Ar score >10 points19, and thus, at their 
consent, they were treated with sodium oxybate 
(50 mg/kg/day) for 2 weeks in association with 
thiamine (100 mg/day) for 4 weeks20. The remain-
ing subjects who did not present any symptoms 
of alcohol withdrawal were advised to make an 
appointment with their general practitioners and 
to undergo abdominal ultrasonography in order 
to investigate whether any liver damage was 
present.
Follow-Up in Subjects With HD
Among subjects with HD (n = 40), only twen-
ty-one of them (2.1% of the whole sample) (21/40) 
were required by the LMDCL to attend a further 
control appointment (T1) at the CAT, while for 
the remaining subjects (n = 19) the LMCDL de-
cided to authorize return of the driving license 
for a very short period of time, suggesting they 
repeated the blood test for the markers of HD, and 
again attending an appointment at the LMCDL 
after 3 months. 
Table I. Characteristics of the whole sample.
  Whole sample Females Males p
Subjects No. subjects (%) 979 (100) 66 (6.7) 913 (93.3) 
Age Mean age (mean ± SD) 41.2 ± 11.8 42.5 ± 10.8 41.1 ± 11.9 0.3451
 No. subjects (%) 
 < 30 years 166 (17.0) 7 (10.6) 159 (17.4) 0.281
 30/39 324 (33.1) 21 (31.8) 303 (33.2) 
 40/49 251 (25.6) 17 (25.8) 234 (25.6) 
 50/59 154 (15.7) 16 (24.2) 138 (15.1) 
 > = 60 54 (8.6) 5 (7.6) 79 (8.7) 
Employment Yes 922 (94.2) 56 (84.8) 866 (94.8) 0.001
 No 57 (5.8) 10 (15.2) 47 (5.2) 
Smoking Yes 660 (67.4) 44 (66.7) 616 (64.5) 0.893
 No 319 (32.6) 22 (33.3) 297 (32.5) 
No. of cigarettes Mean daily use (mean ± SD) 19.6 ± 10.7 20.5 ± 8.2 19.5 ± 10.8 0.5384
≥ 10 cigarettes per day No. of subjects (%) 598 (61.1) 42 (63.6) 556 (60.9) 0.659
Units of alcohol (grams) No. of subjects and mean 359 3.0 ± 1.7 22 2.8 ± 2.0 337 3.0 ± 1.7 0.685
 daily use (mean ± SD)
  No. of subjects and mean 441 2.3 ± 1.1 28  1.9 ± 0.8 413  2.3 ± 1.1 0.1066
 occasional use (mean ± SD)
Binge drinkers  No. of subjects (%) 20 (2.0) 0 (0) 20 (2.0) 
AUDIT score No. of subjects (%)    
 < 8 points 844 (86.2) 56 (5.7) 788 (80.4) 0.486
 8-13 points 108 (11.0) 6 (0.6) 102 (10.4) 
 > 13 points 27 (2.7) 4 (0.4) 23 (2.3) 
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During the T1 appointment, the three patients 
treated for symptoms of alcohol withdrawal who 
had concluded the pharmacological therapy with 
sodium oxybate (CIWA-Ar score was 0) did not 
present any side effects or craving for sodium 
oxybate and declared that they were completely 
abstinent from alcohol. The remaining 18 sub-
jects stated that they had significantly reduced 
their alcohol intake. The improvement of the 
clinical condition of all 21 subjects was observed 
not only by a significant reduction of the blood 
markers of HD between T0 and T1 (Table III), 
but also by a statistically significant reduction of 
the reported units of alcohol per day (3.04 ± 3.08 
vs. 0.90 ± 1.81: p<0.009). While a statistically sig-
nificant reduction of MCV and AST between T0 
and T1 was found, the reduction of GGT levels 
and the AUDIT score did not achieve statistical 
significance; however, an objective trend toward 
reduction of GGT and AUDIT score was ob-
served. The three subjects who manifested symp-
toms of alcohol withdrawal presented a diagnosis 
of severe AUD following the criteria of DSM-V2, 
while after a more accurate clinical investigation, 
14 of the remaining 18 subjects presented a diag-
nosis of mild-moderate AUD. In consideration of 
this, in the final certifications to be given to the 
LMCDL, all these subjects were invited to follow 
a rehabilitation program for AUD at our CAT. 
The LMCDL confirmed what the CAT suggested 
Table III. Difference between Appointment 0 and Appointment 1 in the AUDIT score, and laboratory markers of alcohol 
intake (mean daily and occasional) of the 21 subjects with Harmful Drinking who underwent the follow-up appointment 
(Appointment 1).
 Appointment 0 Appointment 1
 Mean ± Standard Deviation Mean ± Standard Deviation p
AUDIT score 8.4 ± 5.2 5.5 ± 4.3 0.06
AST 79.3 ± 67.9 40.8 ± 22.1 0.02
GGT 256.7 ± 230.0 151.1 ± 197.9 0.1186
MCV 104.1 ± 4.4 99.0 ± 4.8 0.0009
Units of alcohol (g/day) 3.04 ± 3.08  0.90 ± 1.81 0.009
Table II. Comparison between subjects with non-Harmful Drinking versus Harmful Drinking.
  Non Harmful Drinking Harmful Drinking p
Subjects Total (%) 939 (95.9) 40 (4.1) 
 Male (%) 875 (89.3) 38 (4.2) 0.654
 Female (%) 64 (6.5) 2 (3.0) 
Age Mean age (mean ± SD) 41.2 ± 11.8 50.5 ± 8.3 < 0.0001
 No. of subjects (%)
 < 30 years 166 (17.0) 0 (0) < 0.0001
 30/39 321 (32.7) 3 (0.9) 
 40/49 232 (23.6) 19 (7.6) 
 50/59 144 (14.7) 10 (6.5) 
 > = 60 46 (4.6) 8 (9.5) 
Employment Yes 886 (88.4) 36 (3.9) 0.249
 No 53 (5.4) 4 (7.0) 
Smoking Yes 636 (64.9) 24 (3.6) 0.307
 No 303 (30.9) 16 (5.0) 
Number of cigarettes Mean daily use (mean ± SD) 19.6 ± 10.7 24.0 ± 11.6 0.039
  575 (61.1) 23 (57.5) 0.635
Units of alcohol (g) No. of subjects and mean occasional 332 2.9 ± 1.6 27 4.0 ± 2.5 0.002
 use (mean ± SD)
 No. of subjects and  433 2.3 ± 1.1 8 2.1 ± 1.5 0.7325
 mean daily use (mean ± SD) 
 Binge drinkers 19 (2.0) 1 (2.5) 0.835
AUDIT score No. of subjects (%)
 < 8 points 824 (87.8) 20 (50.0) < 0.0001
 8-13 points 92 (9.8) 16 (40.0) 
 > 13 points 23 (2.4) 4 (10.0) 
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and authorized the return of their driving license 
for a very short period (3 months) only if they 
declared they would follow the program proposed 
by our CAT. Data of further follow up appoint-
ments were not recorded in this study.
Discussion
This is the first study investigating the pres-
ence of HD in a population of subjects who had 
their driving license suspended as a result of driv-
ing under the influence of alcohol above the legal 
limit. The study shows a high number of subjects 
driving a car when affected by HD, almost 50% 
of them presented a diagnosis of AUD, were old-
er and heavy smokers. In addition, a monitoring 
protocol of HD (from the police checkpoint to the 
appointment at a CAT) seems to be an efficient 
measure to reduce heavy drinking.
Worldwide, the number of deaths due to HD 
remains high and the difficulties in early iden-
tification is well known4. HD is responsible for 
approximately 5.9% of all deaths worldwide (3.3 
million deaths) and accounts for 5.1% of the glob-
al disease burden1,3, it can lead to approximately 
200 different diseases, including fourteen differ-
ent types of cancer, and it can also have an addic-
tive element1,3. In Italy, it has been estimated that 
among 35 million Italians that habitually drink 
alcohol, 700,000 of them (2%) present HD. In 
addition, as in the rest of Europe4, a very limited 
number (<10%) of subjects with HD or AUD in 
Italy follow a rehabilitation program in a CAT24. 
In our sample, 4.1% of the subjects were affected 
by HD and, 1.7% presented a diagnosis of AUD. 
Namely, they presented a higher risk condition 
for the consequences of alcohol-related problems; 
thus, they may all need to be treated. However, it 
was not possible to draw any comparison with the 
general population since the subjects who tested 
negative at the police checkpoint were not recruit-
ed. On the other hand, our sample consisted of 
subjects driving over the legal limit of alcohol for 
Italian law, putting themselves and others at risk 
of accidents. Indeed, they also present with haz-
ardous drinking which is defined as “a quantity 
or pattern of alcohol consumption that places in-
dividuals at risk for adverse health events”18 giv-
ing the detection of HD a more important value. 
Moreover, during the last two decades, the 
mean age of patients affected by HD or AUD has 
decreased, as indirectly shown by the age of first 
drink in Europe which is around 14-15 years18; 
however, in our study the prevalence of HD in-
creased progressively with the age of the subjects. 
It is conceivable to assert that in a chronic con-
dition, such as alcohol misuse, older subjects are 
more predisposed to develop HD or AUD. This is 
also demonstrated by the fact that almost 50% of 
subjects in the non-HD group were <50 years. In 
addition, the association of alcohol and cigarette 
smoking is frequently found in subjects with HD 
and/or AUD25,26. This data was showed in our 
HD group. In fact, although no differences were 
found in smoking habit, the number of cigarettes 
smoked per day was significantly higher in sub-
jects with HD with respect to those without HD.
Furthermore, the AUDIT test is considered the 
most useful tool for detecting HD in all medical 
settings27. Taking into account that AUDIT is 
a self-administered questionnaire in which the 
participant can deny or minimize his/her alcohol 
habits, in our study we considered its scores with 
caution. In fact, 50% of our subjects affected by 
HD – clearly shown by the alteration of the blood 
markers – did not present a pathological score (<8 
points). This may sound strange, but on the other 
hand, it reflects the fact that subjects tried to mask 
their habits of drinking alcohol during completion 
of the questionnaire. Therefore, the AUDIT ques-
tionnaire alone may not be considered an adequate 
tool for detection of HD; it needs to be combined 
with a clinical evaluation and the results of the 
blood markers of HD to acquire a prominent posi-
tion in detecting the presence of HD.
As regards the laboratory markers, CDT was 
excluded in our analysis. However, while CDT 
is considered a marker of relapse (almost 50-60 
grams of alcohol for at least 10 days)4,14,15, in this 
specific context CDT does not represent a specific 
marker for identification of alcohol-related dam-
age, for which a more complete examination with 
more specific markers of organ damage needs to 
be considered. Indeed, for the detection of HD, 
which was the main purpose of our study, CDT is 
of little use. In addition, CDT needs a very short 
period of time to normalize (10-12 days)14,15, and 
taking into account that our subjects generally 
underwent the first control of markers of HD 
3-4 weeks after the suspension of their driving 
license, they will have had time to stop drinking 
and normalize their blood levels of CDT, present-
ing a normal value at the time of their appoint-
ment at the LMCDL. On the contrary, needing 
a longer period of time to achieve normal values 
(2-3 weeks for GGT and AST, and 2-3 months for 
MCV)4, the other parameters of HD were more 
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helpful. In fact, the 21 subjects with HD who 
attended the follow-up appointment (T1) declared 
they were abstinent or had reduced their alcohol 
intake, as confirmed by a statistically significant 
reduction of all the laboratory parameters of HD. 
On the other hand, it is worth noting that some 
patients may be missed from the diagnosis of HD; 
indeed, some of them may present very modest 
alterations of the laboratory markers of HD which 
normalize at the time of the appointment at the 
LMCDL, and are therefore not required to attend 
an appointment at a CAT.
Despite the moderate quality evidence of the 
efficacy of single brief advice and counseling ses-
sion for HD28, several studies have been published 
to test its efficacy. Since we have no data about 
the recidivism of our subjects, the absence of 
further follow-up appointments, and the absence 
of a control group, it was not possible to collect 
data about the efficacy of the brief counseling 
sessions in a medium or longer period both for 
non-HD and HD subjects. However, in subjects 
with HD a significant improvement of alcohol 
habits in the short-term period was detected, as 
demonstrated by the significant reduction of lab-
oratory markers of HD. It is conceivable to assert 
that the brief counseling session may play a role. 
On the other hand, it is worth noting that subjects 
were extremely motivated to follow a specific 
program to reduce or quit alcohol intake, since 
this would have guaranteed the authorization 
from the LMCDL to drive again. Driving a car 
makes individuals independent, and in the major-
ity of cases makes it possible to go to work with-
out any assistance. To have your driving license 
back could be a strong motivation to abstain from 
alcohol, or to reduce it, particularly in those who 
have not developed physical symptoms of alcohol 
withdrawal in whom this clinical condition would 
be much more difficult.
Limitations
Our study presents some limits. First of all, the 
retrospective evaluation is “per se” a strong limit. 
Secondly, some additional data (i.e., breath alco-
hol test values, concomitant use of medications, 
illicit drugs) which would have more strongly 
characterized our population and our analysis 
were not recorded. Third, any data regarding 
recidivism of our subjects with non-HD were 
not collected, and this would have improved our 
awareness about the efficacy not only of any pe-
nal sanction, but also of the monitoring protocol 
and of the brief counseling session in limiting the 
risk of HD especially in the younger population. 
Fourth, subjects with HD reduced and improved 
their drinking habits; however, no control group 
was recruited, and a very low number of patients 
with HD limits the strength of our data.
Conclusions
In summary, since the 4% and 1.7% of our pop-
ulation with HD and/or AUD are highly at risk for 
the consequences of alcohol-related damage “per 
se” and for other conditions, and considering the 
difficulties in detecting HD and AUD in the gen-
eral population, it is necessary to continue with 
and even increase the roadside check-points, and 
the subsequent monitoring protocol of drinking 
in subjects driving under the influence of alcohol 
and whose driving licenses have been suspend-
ed. Indeed, as already demonstrated both in the 
European Union6,29, and in Anglo-Saxon coun-
tries9,10, prevention policies have been efficient 
in reducing risk of traffic accidents and deaths 
associated with alcohol use. Thus, a monitoring 
program with the involvement of a network of 
several professional figures (policy makers, law-
yers, police forces, experts in forensic medicine, 
and experts in the diagnosis and treatment of 
alcohol addiction) for the detection, and possibly 
treatment of subjects with HD and AUD in this 
context may be implemented. Controlled studies 
to investigate HD and AUD and the efficacy of a 
monitoring protocol of drinking in a population 
of subjects whose driving license has been sus-
pended as a result of driving under the influence 
of alcohol are warranted.
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